Search Results 1711-1720 of 3936 for Solid
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With ...
Participation eligibility · Subjects must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST 1.1) as assessed by the local site ...
Solid organ transplantation (e.g., kidney, pancreas, liver, lung, heart). Active immunosuppression therapy. History of active substance abuse (including ...
Participation eligibility · Age ≥ 18 years. · Histologically or cytologically confirmed solid tumor (cancer) that is metastatic or unresectable and who are ...
* history of allogenic tissue/solid organ transplant. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11/13 ...
* Has had a prior stem cell, bone marrow, allogenic tissue, or solid organ transplant. * Has an active autoimmune disease that has required systemic ...
Hematopoietic stem cell transplantation or solid organ/limb transplantation. 8. Any severe case of Herpes Zoster infection as defined by the protocol. 9 ...
At many transplant centers in the U.S., people who have a high body mass index (BMI) don't qualify for kidney transplant. The traditional cutoff is a BMI ...
Histopathologically or cytologically confirmed advanced solid tumors and advanced lymphoma. In the Dose Escalation and Dose Expansion Phases, both Parts A ...
... Solid Tumors, Version 1.1 (RECIST v1.1) * Baseline tumor tissue samples will be collected from all participants for exploratory biomarker research
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.